194 related articles for article (PubMed ID: 37822353)
1. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
Al-Zubaidi HK; Hughes SF
Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
[No Abstract] [Full Text] [Related]
2. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
Poongodi R; Varma N; Naseem S; Parveen B; Varma S
Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
[TBL] [Abstract][Full Text] [Related]
3. A Flow Cytometry Panel for Differential Diagnosis of Mantle Cell Lymphoma from Atypical B-Chronic Lymphocytic Leukaemia.
Mehrpouri M; Sadat Hosseini M; Jafari L; Mosleh M; Shahabi Satlsar E
Iran Biomed J; 2023 Jan; 27(1):15-22. PubMed ID: 36624655
[TBL] [Abstract][Full Text] [Related]
4. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.
Mason EF; Pozdnyakova O; Li B; Dudley G; Dorfman DM
Am J Clin Pathol; 2017 Jul; 148(1):33-41. PubMed ID: 28575142
[TBL] [Abstract][Full Text] [Related]
5. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
[TBL] [Abstract][Full Text] [Related]
6. The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
[TBL] [Abstract][Full Text] [Related]
7. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
[TBL] [Abstract][Full Text] [Related]
8. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
Li W; Fang P; Fu G; Liang H; Peng M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
[TBL] [Abstract][Full Text] [Related]
9. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
[TBL] [Abstract][Full Text] [Related]
10. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
[TBL] [Abstract][Full Text] [Related]
11. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.
Sandes AF; de Lourdes Chauffaille M; Oliveira CR; Maekawa Y; Tamashiro N; Takao TT; Ritter EC; Rizzatti EG
Cytometry B Clin Cytom; 2014 Mar; 86(2):98-105. PubMed ID: 24243815
[TBL] [Abstract][Full Text] [Related]
12. CD200 expression in B-cell chronic lymphoproliferative disorders.
El Desoukey NA; Afify RA; Amin DG; Mohammed RF
J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
[TBL] [Abstract][Full Text] [Related]
13. Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
Sorigue M; Magnano L; Miljkovic MD; Nieto-Moragas J; Santos-Gomez M; Villamor N; Junca J; Morales-Indiano C
Cytometry B Clin Cytom; 2020 Sep; 98(5):441-448. PubMed ID: 31692239
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis.
Fan L; Miao Y; Wu YJ; Wang Y; Guo R; Wang L; Shen AL; Chen YY; Xu W; Li JY
Leuk Lymphoma; 2015; 56(12):3329-35. PubMed ID: 25791119
[TBL] [Abstract][Full Text] [Related]
15. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
16. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
[No Abstract] [Full Text] [Related]
17. CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry.
Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA
Int J Lab Hematol; 2018 Oct; 40(5):533-539. PubMed ID: 29806244
[TBL] [Abstract][Full Text] [Related]
18. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
[TBL] [Abstract][Full Text] [Related]
19. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
[TBL] [Abstract][Full Text] [Related]
20. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]